PA
CMD

Parallel Advisors’s Cantel Medical Corporation CMD Stock Holding History

Parallel Advisors’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-23
Closed -$2K – 3168
2021
Q1 		$2K Buy
+23
New +$1.8K ﹤0.01% 2561
2020
Q2 		– Sell
-93
Closed -$3K – 2817
2020
Q1 		$3K Sell
93
-550
-86% -$31.3K ﹤0.01% 2087
2019
Q4 		$46K Sell
643
-6
-0.9% -$435 ﹤0.01% 1063
2019
Q3 		$49K Hold
649
– – ﹤0.01% 1002
2019
Q2 		$52K Buy
649
+395
+156% +$27.8K 0.01% 891
2019
Q1 		$17K Sell
254
-618
-71% -$46.8K ﹤0.01% 1301
2018
Q4 		$64K Hold
872
– – 0.01% 678
2018
Q3 		$80K Buy
872
+662
+315% +$63.1K 0.01% 659
2018
Q2 		$20K Hold
210
– – ﹤0.01% 1062
2018
Q1 		$23K Hold
210
– – ﹤0.01% 964
2017
Q4 		$22K Hold
210
– – ﹤0.01% 991
2017
Q3 		$21K Hold
210
– – ﹤0.01% 993
2017
Q2 		$16K Buy
210
+9
+4% +$676 ﹤0.01% 1114
2017
Q1 		$15K Buy
201
+71
+55% +$5.64K ﹤0.01% 1073
2016
Q4 		$10K Buy
+130
New +$10.1K ﹤0.01% 1132

Parallel Advisors's CMD Position: Q2 2021 in Review

Parallel Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 23 shares — an estimated $2K sold.

Parallel Advisors first reported a position in CMD in Q4 2016 and held it in 15 quarters. The position peaked at $80K in Q3 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Parallel Advisors reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Parallel Advisors sold 23 Cantel Medical Corporation shares in Q2 2021, an estimated $2K.
  • Parallel Advisors first reported a position in Cantel Medical Corporation in Q4 2016 and held it in 15 quarters.
  • Parallel Advisors's Cantel Medical Corporation position peaked at $80K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Parallel Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.